Explore / Peer-reviewed article
Peer-reviewed articleOpen access

Effect of oral tryptamines on the gut microbiome of rats-a preliminary study.

Xu M, Kiss AJiD, Jones JAiD, McMurray MSiD, Shi H

PeerJJun 3, 2024License: open accessUnited States4 citationsDOI: 10.7717/peerj.17517

Abstract

<h4>Background</h4>Psilocybin and related tryptamines have come into the spotlight in recent years as potential therapeutics for depression. Research on the mechanisms of these effects has historically focused on the direct effects of these drugs on neural processes. However, in addition to such neural effects, alterations in peripheral physiology may also contribute to their therapeutic effects. In particular, substantial support exists for a gut microbiome-mediated pathway for the antidepressant efficacy of other drug classes, but no prior studies have determined the effects of tryptamines on microbiota.<h4>Methods</h4>To address this gap, in this preliminary study, male Long Evans rats were treated with varying dosages of oral psilocybin (0.2 or 2 mg/kg), norbaeocystin (0.25 or 2.52 mg/kg), or vehicle and their fecal samples were collected 1 week and 3 weeks after exposure for microbiome analysis using integrated 16S ribosomal DNA sequencing to determine gut microbiome composition.<h4>Results</h4>We found that although treatment with neither psilocybin nor norbaeocystin significantly affected overall microbiome diversity, it did cause significant dose- and time-dependent changes in bacterial abundance at the phylum level, including increases in <i>Verrucomicrobia</i> and <i>Actinobacteria</i>, and decreases in <i>Proteobacteria</i>.<h4>Conclusion and implications</h4>These preliminary findings support the idea that psilocybin and other tryptamines may act on the gut microbiome in a dose- and time-dependent manner, potentially identifying a novel peripheral mechanism for their antidepressant activity. The results from this preliminary study also suggest that norbaeocystin may warrant further investigation as a potential antidepressant, given the similarity of its effects to psilocybin.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinDepression

Keywords

RatActinobacteriaVerrucomicrobiaProteobacteriaGut MicrobiomeNorbaeocystin

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.